Oxford University given £100m to launch fight against antibiotic resistance January 19, 2021 The University of Oxford has been given £100m for a new institute focusing on resistance to antibiotics, one of the largest donations in its history. The gift will help combat the global issue of antimicrobial resistance (AMR), which is one of the world’s greatest healthcare challenges. The funding has been delivered by chemicals giant INEOS [...]
First psychedelic healthcare fund launches in Britain December 18, 2020 Britain’s first investment fund dedicated solely to psychedelic healthcare launched this week, allowing investors to put money into mind altering drugs for medical use. The fund, launched by London-based venture capital firm Neo Kuma, has an investment thesis focused on clinically proven psychedelic medicines that it believes will hit the market in the next five [...]
The new drug habits October 21, 2005 Pharmaceutical companies are increasingly turning to biotechnology ventures to help them rescue their flagging profits. Investors are looking at biotechnology companies to reinvigorate a moribund drug industry in a way the big pharmaceutical giants have failed to do over the last two years. Observers say companies such as America’s Pfizer or Britain’s GlaxoSmithKline, known as [...]
Flu anti-virus causes 17% profit jump October 20, 2005 Roche, the maker of bird flu anti-viral Tamiflu, yesterday announced a third quarter revenue increase of 17 per cent thanks to a jump in sales of the drug. The Swiss firm said sales of Tamiflu had more than doubled to SFr279m (£123m) and the companies overall sales for the quarter ending September climbed to SFr8.8bn. [...]